Ninety One North America’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-21,299
Closed -$2.3M 127
2018
Q2
$2.3M Sell
21,299
-497
-2% -$54.1K 0.17% 93
2018
Q1
$2.31M Buy
+21,796
New +$2.53M 0.18% 83
2017
Q3
Sell
-17,746
Closed -$2.21M 84
2017
Q2
$2.21M Buy
17,746
+1,164
+7% +$138K 0.41% 45
2017
Q1
$1.97M Sell
16,582
-304
-2% -$34.5K 0.37% 47
2016
Q4
$1.69M Sell
16,886
-196
-1% -$21K 0.25% 74
2016
Q3
$2.16M Hold
17,082
0.29% 79
2016
Q2
$2M Buy
17,082
+2,369
+16% +$268K 0.29% 75
2016
Q1
$1.52M Buy
14,713
+4,213
+40% +$408K 0.25% 76
2015
Q4
$1.05M Hold
10,500
0.19% 77
2015
Q3
$958K Buy
10,500
+282
+3% +$28.3K 0.24% 74
2015
Q2
$1.08M Hold
10,218
0.35% 50
2015
Q1
$1.17M Hold
10,218
0.36% 50
2014
Q4
$1.13M Buy
+10,218
New +$1.08M 0.33% 52

Other funds holding ZBH

Ninety One North America's ZBH Position: Q3 2018 in Review

Ninety One North America sold out of Zimmer Biomet (ZBH) in Q3 2018, closing a stake of 21,299 shares — an estimated $2.3M sold.

Ninety One North America first reported a position in ZBH in Q4 2014 and held it in 13 quarters. The position peaked at $2.31M in Q1 2018. 891 funds tracked by Wall St. Rank hold ZBH as of Q3 2018.

  • Ninety One North America reported no remaining Zimmer Biomet position as of Q3 2018 after selling out during the quarter.
  • Ninety One North America sold 21,299 Zimmer Biomet shares in Q3 2018, an estimated $2.3M.
  • Ninety One North America first reported a position in Zimmer Biomet in Q4 2014 and held it in 13 quarters.
  • Ninety One North America's Zimmer Biomet position peaked at $2.31M in Q1 2018.
  • 891 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2018.

Based on Ninety One North America's 13F filing for Q3 2018, filed 13 Nov 2018.